Baig MS - Search Results

1

Matrix Metalloproteinases (MMPs) in Liver Diseases.

Naim A, Pan Q, Baig MS. Naim A, et al. Among authors: baig ms. J Clin Exp Hepatol. 2017 Dec;7(4):367-372. doi: 10.1016/j.jceh.2017.09.004. Epub 2017 Oct 3. J Clin Exp Hepatol. 2017. PMID: 29234202 Free PMC article. Review.

2

The TLR4-NOS1-AP1 signaling axis regulates macrophage polarization.

Srivastava M, Saqib U, Naim A, Roy A, Liu D, Bhatnagar D, Ravinder R, Baig MS. Srivastava M, et al. Among authors: baig ms. Inflamm Res. 2017 Apr;66(4):323-334. doi: 10.1007/s00011-016-1017-z. Epub 2016 Dec 24. Inflamm Res. 2017. PMID: 28013342

3

Heterotrimeric complex of p38 MAPK, PKCδ, and TIRAP is required for AP1 mediated inflammatory response.

Baig MS, Liu D, Muthu K, Roy A, Saqib U, Naim A, Faisal SM, Srivastava M, Saluja R. Baig MS, et al. Int Immunopharmacol. 2017 Jul;48:211-218. doi: 10.1016/j.intimp.2017.04.028. Epub 2017 May 18. Int Immunopharmacol. 2017. PMID: 28528205

4

Repurposing Thioridazine (TDZ) as an anti-inflammatory agent.

Baig MS, Roy A, Saqib U, Rajpoot S, Srivastava M, Naim A, Liu D, Saluja R, Faisal SM, Pan Q, Turkowski K, Darwhekar GN, Savai R. Baig MS, et al. Sci Rep. 2018 Aug 20;8(1):12471. doi: 10.1038/s41598-018-30763-5. Sci Rep. 2018. PMID: 30127400 Free PMC article.

5

Matrix metalloproteinase-8 (MMP-8) regulates the activation of hepatic stellate cells (HSCs) through the ERK-mediated pathway.

Naim A, Baig MS. Naim A, et al. Among authors: baig ms. Mol Cell Biochem. 2020 Apr;467(1-2):107-116. doi: 10.1007/s11010-020-03705-x. Epub 2020 Feb 27. Mol Cell Biochem. 2020. PMID: 32108279

6

A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.

Rajpoot S, Ohishi T, Kumar A, Pan Q, Banerjee S, Zhang KYJ, Baig MS. Rajpoot S, et al. Among authors: baig ms. Drugs R D. 2021 Sep;21(3):273-283. doi: 10.1007/s40268-021-00357-0. Epub 2021 Jul 29. Drugs R D. 2021. PMID: 34324175 Free PMC article.

7

Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses.

Wang Y, Li P, Solanki K, Li Y, Ma Z, Peppelenbosch MP, Baig MS, Pan Q. Wang Y, et al. Among authors: baig ms. Virology. 2021 Dec;564:33-38. doi: 10.1016/j.virol.2021.09.009. Epub 2021 Oct 2. Virology. 2021. PMID: 34619630 Free PMC article.

8

Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models.

Wang Y, Li P, Rajpoot S, Saqib U, Yu P, Li Y, Li Y, Ma Z, Baig MS, Pan Q. Wang Y, et al. Among authors: baig ms. Sci Rep. 2021 Dec 6;11(1):23465. doi: 10.1038/s41598-021-02972-y. Sci Rep. 2021. PMID: 34873274 Free PMC article.

9

In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern.

Rajpoot S, Solanki K, Kumar A, Zhang KYJ, Pullamsetti SS, Savai R, Faisal SM, Pan Q, Baig MS. Rajpoot S, et al. Among authors: baig ms. Int J Pept Res Ther. 2022;28(1):28. doi: 10.1007/s10989-021-10339-0. Epub 2021 Dec 13. Int J Pept Res Ther. 2022. PMID: 34924897 Free PMC article.

10

Differing pan-coronavirus antiviral potency of boceprevir and GC376 in vitro despite discordant molecular docking predictions.

Wang Y, Li P, Lavrijsen M, Li Y, Ma Z, Peppelenbosch MP, Baig MS, Pan Q. Wang Y, et al. Among authors: baig ms. Arch Virol. 2022 Apr;167(4):1125-1130. doi: 10.1007/s00705-022-05369-y. Epub 2022 Feb 16. Arch Virol. 2022. PMID: 35171357 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page